Skip to main content
View the latest BOT/BAL presentation from ESMO-GI

Press Releases

Spotlight

December 10, 2025

Agenus Reports Q3 2025 Results Showcasing Clinical
and Regulatory Advances Copy 11

Download
Select Year:
All Years
Link Template
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
December 10, 2025
2025

Agenus Reports Q3 2025 Results Showcasing Clinical
and Regulatory Advances Copy 11

Download
December 10, 2025
2025

Agenus Reports Q3 2025 Results Showcasing Clinical
and Regulatory Advances Copy 10

Download
December 10, 2025
2025

Agenus Reports Q3 2025 Results Showcasing Clinical
and Regulatory Advances Copy 9

Download
December 10, 2025
2025

Agenus Reports Q3 2025 Results Showcasing Clinical
and Regulatory Advances Copy 8

Download
December 10, 2025
2022

Agenus Reports Q3 2025 Results Showcasing Clinical
and Regulatory Advances Copy 7

Download

Investor Email Alerts

Sign Up
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Contact Us

Agenus Inc.
investor@agenusbio.com

Quick Links

SEC Filings
Information Request Form
Request A Meeting With Management
Agenus Inc.
3 Forbes Road
Lexington, MA 02421-7305
T: +1 (781) 674 4400 | F: +1 (781) 674 4200
Our Science
Pipeline
Publications
Clinical Trials
Immunotherapy
About BOT + BAL
Company
Our History
Our Team
Careers
Partners
Access
Patient Access
Contact Medical Affairs
Resources
Press Releases
In the News
Patient Resources
FAQs
Investors
Investor Overview
Events
Financial Information
Opt-out preferencesCookie PolicyTerms and Conditions of UsePrivacy PolicyCommunity GuidelinesAccess to Investigational Medicines PolicyReport Adverse EventInvestor Portal
© 2025 Agenus Inc. All rights reserved.